A detailed history of Frazier Life Sciences Management, L.P. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,062,558 shares of PBYI stock, worth $8.61 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
3,062,558
Previous 3,062,558 -0.0%
Holding current value
$8.61 Million
Previous $9.98 Million 21.78%
% of portfolio
0.42%
Previous 0.59%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$2.92 - $5.83 $719,090 - $1.44 Million
246,264 Added 8.74%
3,062,558 $9.98 Million
Q1 2024

May 15, 2024

BUY
$4.29 - $7.4 $12.1 Million - $20.8 Million
2,816,294 New
2,816,294 $14.9 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $128M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.